Pharmaceuticals · Pharmaceuticals: Major · NSE: ALPA · data 2026-10-30

Alpa Laboratories Limited

₹50.38-4.26% on 30 OctHealth: Average 4.3/10

Feb 2026Low ₹46.46 · High ₹74.57-29.0%

In plain words

Price: 45.5% below its 52-week high of ₹92.5.

Delivery: 71.2% of traded shares were kept for delivery over the last 10 sessions, against 63.9% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹50.38

Market cap

₹111 cr

P/E

24.2

P/B

—

ROE

8.4%

ROCE

0.7%

Debt / equity

0.01

Dividend yield

0.00%

1-year return

-45.2%

52-week high

₹92.5

52-week low

₹46.1

Operating margin

-3.0%

Growth

Revenue (last 12 months)	₹111 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	4.4%
Profit growth, 3 years (yearly)	6.1%

Smart-money activity

12/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 7/30: Delivery 64.6% over the last 20 sessions vs 54.2% in the 40 before (1.19x); shares delivered per day 0.58x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Alpa Laboratories Limited debt-free?

Its latest reported debt-to-equity ratio is 0.01, which is very low.

What is Alpa Laboratories Limited's P/E ratio?

About 24.2, based on the last 12 months' earnings and a price of ₹50.38 (data 2026-10-30).

What is the 52-week high and low of Alpa Laboratories Limited?

The 52-week high is ₹92.5 and the 52-week low is ₹46.1.

Similar companies

Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Parnax Lab Limited (PARNAXLAB) · Sotac Pharmaceuticals Limited (SOTAC) · Makers Laboratories Ltd (MAKERSL) · Vaishali Pharma Ltd. (VAISHALI)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ALPA in NSE Scanner →